BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38393358)

  • 1. [Premenstrual syndrome and premenstrual dysphoric disorder-Overview on pathophysiology, diagnostics and treatment].
    Haußmann J; Goeckenjan M; Haußmann R; Wimberger P
    Nervenarzt; 2024 Mar; 95(3):268-274. PubMed ID: 38393358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Premenstrual syndrome and premenstrual dysphoric disorder].
    Kovács Z; Hegyi G; Szőke H
    Orv Hetil; 2022 Jun; 163(26):1023-1031. PubMed ID: 35895486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate.
    Dunphy L; Boyle S; Wood F
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38160030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].
    Marais-Thomas H; Chapelle F; de Vaux-Boitouzet V; Bouvet C
    Encephale; 2024 Apr; 50(2):211-232. PubMed ID: 37821319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychiatric and psychological aspects of premenstrual syndrome].
    Limosin F; Ades J
    Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
    Naheed B; Kuiper JH; Uthman OA; O'Mahony F; O'Brien PM
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010503. PubMed ID: 28257559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of premenstrual dysphoric disorder with the GABA
    Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
    Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premenstrual Syndrome and Premenstrual Dysphoric Disorder.
    Hofmeister S; Bodden S
    Am Fam Physician; 2016 Aug; 94(3):236-40. PubMed ID: 27479626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
    Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
    Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenstrual syndrome.
    Dickerson LM; Mazyck PJ; Hunter MH
    Am Fam Physician; 2003 Apr; 67(8):1743-52. PubMed ID: 12725453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Premenstrual syndrome and dysphoric premenstrual syndrome].
    Alba P; Rodríguez C
    Vertex; 2014; 25(117):370-6. PubMed ID: 25545084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premenstrual disorders.
    Yonkers KA; Simoni MK
    Am J Obstet Gynecol; 2018 Jan; 218(1):68-74. PubMed ID: 28571724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder.
    Freeman EW
    Curr Psychiatry Rep; 2002 Dec; 4(6):435-40. PubMed ID: 12441023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A scoping review of hormonal clinical trials in menstrual cycle-related brain disorders: Studies in premenstrual mood disorder, menstrual migraine, and catamenial epilepsy.
    Barone JC; Butler MP; Ross A; Patterson A; Wagner-Schuman M; Eisenlohr-Moul TA
    Front Neuroendocrinol; 2023 Oct; 71():101098. PubMed ID: 37619655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic and therapeutic algorithm for the treatment of premenstrual dysphoric disorder].
    Strkalj Ivezić S; Kusan Jukić M; Tikvica A; Pavicić Baldani D
    Acta Med Croatica; 2010 Jul; 64(3):183-90. PubMed ID: 20922861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grey matter morphology in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator.
    Kaltsouni E; Dubol M; Wikström J; Lanzenberger R; Sundström-Poromaa I; Comasco E
    Eur Neuropsychopharmacol; 2022 Dec; 65():35-43. PubMed ID: 36343426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder.
    Rapkin AJ; Akopians AL
    Menopause Int; 2012 Jun; 18(2):52-9. PubMed ID: 22611222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premenstrual syndrome.
    Yonkers KA; O'Brien PM; Eriksson E
    Lancet; 2008 Apr; 371(9619):1200-10. PubMed ID: 18395582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.